Narmada Gelatines Ltd
Incorporated in 1969, Narmada Gelatines Ltd manufactures and sells Gelatine and Ossein[1]
- Market Cap ₹ 218 Cr.
- Current Price ₹ 360
- High / Low ₹ 449 / 300
- Stock P/E 11.8
- Book Value ₹ 197
- Dividend Yield 2.78 %
- ROCE 19.9 %
- ROE 15.1 %
- Face Value ₹ 10.0
Pros
- Company has been maintaining a healthy dividend payout of 157%
Cons
- The company has delivered a poor sales growth of 7.07% over past five years.
- Company has a low return on equity of 13.8% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
130 | 134 | 131 | 113 | 118 | 126 | 134 | 135 | 157 | 191 | 182 | 189 | 191 | |
106 | 113 | 120 | 109 | 112 | 116 | 120 | 127 | 143 | 171 | 161 | 164 | 165 | |
Operating Profit | 24 | 21 | 11 | 4 | 5 | 9 | 14 | 8 | 15 | 20 | 21 | 25 | 27 |
OPM % | 19% | 16% | 8% | 3% | 5% | 7% | 11% | 6% | 9% | 10% | 12% | 13% | 14% |
3 | 4 | 3 | 6 | 4 | 5 | 6 | 6 | 3 | 2 | 2 | 2 | 1 | |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
Depreciation | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 |
Profit before tax | 25 | 23 | 13 | 8 | 8 | 13 | 18 | 11 | 15 | 20 | 21 | 23 | 24 |
Tax % | 35% | 34% | 36% | 27% | 5% | 24% | 28% | 26% | 20% | 23% | 26% | 24% | |
16 | 16 | 8 | 6 | 8 | 10 | 13 | 8 | 12 | 15 | 15 | 17 | 18 | |
EPS in Rs | 27.10 | 25.62 | 13.70 | 10.10 | 13.29 | 16.63 | 21.29 | 13.98 | 20.40 | 25.26 | 25.34 | 28.45 | 30.49 |
Dividend Payout % | 12% | 14% | 29% | 40% | 30% | 60% | 47% | 72% | 49% | 396% | 39% | 35% |
Compounded Sales Growth | |
---|---|
10 Years: | 3% |
5 Years: | 7% |
3 Years: | 6% |
TTM: | 6% |
Compounded Profit Growth | |
---|---|
10 Years: | 2% |
5 Years: | 12% |
3 Years: | 17% |
TTM: | 23% |
Stock Price CAGR | |
---|---|
10 Years: | 9% |
5 Years: | 14% |
3 Years: | 16% |
1 Year: | -7% |
Return on Equity | |
---|---|
10 Years: | 8% |
5 Years: | 10% |
3 Years: | 14% |
Last Year: | 15% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 4 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
Reserves | 88 | 98 | 103 | 112 | 118 | 125 | 130 | 133 | 139 | 88 | 103 | 113 |
2 | 1 | 2 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 13 | |
16 | 15 | 17 | 21 | 16 | 22 | 24 | 26 | 25 | 23 | 25 | 27 | |
Total Liabilities | 109 | 120 | 128 | 140 | 140 | 155 | 161 | 165 | 170 | 117 | 134 | 159 |
24 | 23 | 23 | 22 | 25 | 24 | 26 | 29 | 27 | 28 | 27 | 33 | |
CWIP | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 0 | 0 | 0 | 0 | 7 |
Investments | 25 | 27 | 34 | 45 | 53 | 68 | 65 | 50 | 48 | 4 | 10 | 41 |
61 | 70 | 72 | 73 | 62 | 61 | 69 | 85 | 94 | 85 | 97 | 78 | |
Total Assets | 109 | 120 | 128 | 140 | 140 | 155 | 161 | 165 | 170 | 117 | 134 | 159 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
10 | 6 | 7 | 7 | 9 | 12 | 5 | 3 | 2 | 14 | 15 | 17 | |
-10 | -0 | -7 | -2 | -2 | -5 | -4 | 6 | 10 | 44 | -12 | -29 | |
-1 | -3 | -2 | -5 | -3 | -1 | -9 | -7 | -6 | -67 | -0 | 5 | |
Net Cash Flow | -1 | 3 | -2 | 0 | 4 | 6 | -8 | 2 | 6 | -9 | 2 | -6 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 40 | 41 | 47 | 52 | 59 | 56 | 55 | 48 | 36 | 37 | 44 | 48 |
Inventory Days | 174 | 194 | 169 | 192 | 144 | 144 | 166 | 166 | 185 | 152 | 161 | 155 |
Days Payable | 33 | 21 | 23 | 52 | 40 | 62 | 63 | 62 | 57 | 42 | 50 | 57 |
Cash Conversion Cycle | 182 | 214 | 193 | 193 | 163 | 138 | 158 | 152 | 164 | 147 | 155 | 146 |
Working Capital Days | 98 | 117 | 120 | 146 | 127 | 95 | 108 | 115 | 119 | 97 | 103 | 88 |
ROCE % | 28% | 21% | 12% | 4% | 5% | 7% | 11% | 5% | 10% | 16% | 20% | 20% |
Documents
Announcements
- Announcement under Regulation 30 (LODR)-Newspaper Publication 9h
- Intimation Of Date Of 64Th Annual General Meeting Of The Company 1d
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
14 Aug - Newspaper Advertisement- Disclosure under Regulation 30 and 47 of SEBI (LODR) Regulations, 2015
-
Board Meeting Outcome for Outcomes Of The Board Meeting
13 Aug - Q1 FY2026 unaudited results approved; auditor fee revised to Rs 7.5 lakh p.a., subject to shareholder approval.
- Unaudited Standalone And Consolidated Financial Results For The Quarter Ended 30Th June, 2025 13 Aug
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Business Overview:[1]
Company is engaged in the manufacture
of ossein and gelatin. It is located at Jabalpur
and has access to its main and essential
inputs of crushed bones, acid, lime and
water